Merit Medical Systems, Inc.
Financials
Valuation Metrics
Merit Medical Systems, Inc.'s Market Cap is $5.10B. At end of 2025 it was $5.23B. Ranked #1385 of 3,112 in US market (top 45%), #479 of 1,445 on NASDAQ (top 33%), #84 of 206 in Health Care Equipment & Services (top 41%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.10B | US#1,385/3,112 Sec#84/206 |
| Revenue | $1.58B | US#1,623/3,112 Sec#98/206 |
| Net Income | $146M | US#1,428/3,112 Sec#68/206 |
| Total Assets | $2.86B | US#1,831/3,112 Sec#89/206 |
| Net Assets | $1.68B | US#1,386/3,112 Sec#72/206 |
| Employees | 7,500 | US#696/3,112 Sec#64/206 |
| Value | ||
| P/E | 35.05x | US#1,593/3,112 Sec#63/206 |
| P/B | 3.04x | US#1,689/3,112 Sec#100/206 |
| PEG | 1.84x | US#1,020/3,112 Sec#47/206 |
| P/S | 3.23x | US#1,840/3,112 Sec#127/206 |
| EV/EBITDA | 21.44x | US#1,926/3,112 Sec#91/206 |
| FCF Yield | 4.67% | US#1,350/3,112 Sec#71/206 |
| Profitability | ||
| ROE | 8.67% | US#1,521/3,112 Sec#74/206 |
| ROA | 5.08% | US#981/3,112 Sec#62/206 |
| Op. Margin | 12.72% | US#1,403/3,112 Sec#58/206 |
| Revenue Growth | 9.52% | US#1,336/3,112 Sec#95/206 |
| Earnings Growth | 19.10% | US#944/3,112 Sec#44/206 |
| Financial Health | ||
| Debt Ratio | 70.47% | US#788/3,112 Sec#84/206 |
| Total Debt | $867M | US#1,551/3,112 Sec#82/206 |
| FCF | $238M | US#1,254/3,112 Sec#73/206 |
| Cash | $449M | US#1,145/3,112 Sec#68/206 |
| Current Ratio | 4.20x | US#573/3,112 Sec#57/206 |
| Net Debt/EBITDA | 1.63x | US#1,246/3,112 Sec#69/206 |
| Performance | ||
| 1Y Return | 0.88% | US#2,076/3,112 Sec#143/206 |
| 1M Return | 20.31% | US#139/3,112 Sec#21/206 |
| From 52W High | -9.73% | US#1,020/3,112 Sec#72/206 |
| 1Y MDD | -38.98% | US#1,899/3,112 Sec#101/206 |
| Trading | ||
| Volume | 1,535,365 shares | US#1,099/3,112 Sec#66/206 |
| Trading Value | $132M | US#727/3,112 Sec#59/206 |
| Per Share | ||
| EPS | $2.17 | US#1,214/3,112 Sec#62/206 |
| BPS | $26.70 | US#961/3,112 Sec#59/206 |
Company Info
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.